loading
Vigil Neuroscience Inc stock is traded at $8.08, with a volume of 12,983. It is up +0.12% in the last 24 hours and up +1.64% over the past month. Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
See More
Previous Close:
$8.06
Open:
$8.07
24h Volume:
12,983
Relative Volume:
0.01
Market Cap:
$384.83M
Revenue:
-
Net Income/Loss:
$-82.60M
P/E Ratio:
-3.9223
EPS:
-2.06
Net Cash Flow:
$-48.61M
1W Performance:
+0.00%
1M Performance:
+1.64%
6M Performance:
+243.40%
1Y Performance:
+102.26%
1-Day Range:
Value
$8.0698
$8.09
1-Week Range:
Value
$8.06
$8.10
52-Week Range:
Value
$1.312
$8.10

Vigil Neuroscience Inc Stock (VIGL) Company Profile

Name
Name
Vigil Neuroscience Inc
Name
Phone
857-254-4445
Name
Address
100 FORGE ROAD, WATERTOWN
Name
Employee
67
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
VIGL's Discussions on Twitter

Compare VIGL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VIGL
Vigil Neuroscience Inc
8.07 376.17M 0 -82.60M -48.61M -2.06
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.29 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.80 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.34 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
570.41 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.31 29.19B 3.81B -644.79M -669.77M -6.24

Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades

Date Action Analyst Rating Change
May-28-25 Downgrade Stifel Buy → Hold
Dec-04-24 Initiated William Blair Outperform
Dec-19-23 Downgrade Morgan Stanley Equal-Weight → Underweight
Oct-18-23 Initiated JMP Securities Mkt Outperform
Mar-31-23 Initiated Mizuho Buy
Sep-16-22 Initiated Wedbush Outperform
Aug-29-22 Initiated H.C. Wainwright Buy
Feb-01-22 Initiated Guggenheim Buy
Feb-01-22 Initiated Jefferies Buy
Feb-01-22 Initiated Morgan Stanley Equal-Weight
Feb-01-22 Initiated Stifel Buy
View All

Vigil Neuroscience Inc Stock (VIGL) Latest News

pulisher
Jul 22, 2025

Vigil Neuroscience Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Vigil Neuroscience Inc. stockFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Vigil Neuroscience Inc. stock priceGame-changing capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Vigil Neuroscience Inc. a good long term investmentStrong return on assets - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period - Investing.com Australia

Jul 17, 2025
pulisher
Jul 15, 2025

How Vigil Neuroscience Inc. stock performs during market volatilityIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Vigil Neuroscience Inc. stock attracts strong analyst attention10x Potential Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Vigil Neuroscience Inc. stock price move sharplyFree VIP Investment Strategies - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80 - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders - MarketScreener

Jul 14, 2025
pulisher
Jul 14, 2025

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc.VIGL - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

TREM2 agonists reported in Vigil Neuroscience patents - BioWorld MedTech

Jul 14, 2025
pulisher
Jul 09, 2025

Vigil Neuroscience (NASDAQ:VIGL) Stock Price Up 0.4% – Here’s What Happened - Defense World

Jul 09, 2025
pulisher
Jul 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: TASK, VIGL, STRM, and CHTR - The Malaysian Reserve

Jul 04, 2025
pulisher
Jun 30, 2025

Vigil Neuroscience Announces Special Meeting for Sanofi Merger Vote - TipRanks

Jun 30, 2025
pulisher
Jun 25, 2025

Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High? - Nasdaq

Jun 25, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet - MSN

Jun 09, 2025
pulisher
Jun 05, 2025

Vigil Neuroscience: ALSP Data Doesn't Deliver, But Sanofi Purchase Remains Intact (VIGL) - Seeking Alpha

Jun 05, 2025
pulisher
Jun 05, 2025

Vigil Neuroscience fails in mid-stage study for lead asset - MSN

Jun 05, 2025

Vigil Neuroscience Inc Stock (VIGL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Vigil Neuroscience Inc Stock (VIGL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Magovcevic-Liebisch Ivana
President and CEO
Dec 19 '24
Buy
1.68
5,000
8,400
222,687
Magovcevic-Liebisch Ivana
President and CEO
Dec 18 '24
Buy
1.67
5,000
8,350
217,687
Magovcevic-Liebisch Ivana
President and CEO
Dec 05 '24
Buy
2.34
5,000
11,700
212,687
$22.80
price up icon 4.56%
$36.00
price down icon 0.33%
$102.46
price down icon 0.38%
$27.75
price up icon 4.50%
$113.56
price up icon 1.86%
biotechnology ONC
$295.32
price down icon 0.11%
Cap:     |  Volume (24h):